The story of Sildenafil presents a complex case for investors in the medicinal sector. While initially a phenomenal success, creating vast sums, the patent lapse and the subsequent arrival of off-brand versions have https://adult968527.ivasdesign.com/62936906/viagra-and-big-pharma-a-risky-play